Biotech & MedTech News
-
Zentek to Showcase ZenGUARD(TM) for HVAC at BUILDEX Alberta 2023
September 25, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company…
-
Zentek Announces Annual General Meeting on Thursday October 5th, 2023, at the Delta Hotel in Guelph, Ontario
September 21, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead…
-
Hemostemix Announces New Publication: How NCP-01 Supports Brain Computer Interfaces
September 12, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce its…
-
Zentek’s ZenGUARD(TM)-Enhanced Filters Demonstrate Robust Return on Investment in ParticleOne Study
September 11, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Zentek Announces Breakthrough Results in Viral Filtration Efficiency with Dust Loading
September 06, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization…
-
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications
August 29, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
Zentek Announces Distribution and Supply Agreement with Henry Schein, Inc.
August 24, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company…
-
Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement
August 14, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that…
-
FendX Receives DTC Eligibility
August 9, 2023 (Source) – FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the”Company” or “FendX”), a…
